As a counselor, you will be making decisions on how to select evidence-based treatments. In your essay, demonstrate the decision-making process
As a counselor, you will be making decisions on how to select evidence-based treatments. In your essay, demonstrate the decision-making process that you will use to choose one evidence-based treatment over another. Write a 1,000-1,250-word reflection essay on how to effectively utilize research in order to guide decision-making processes in the counseling profession. Include the following in your essay:
- A discussion about how qualitative and quantitative research reports guide the decision-making process.
- A discussion about the key characteristics of effective writing and publication in counseling and psychological research. How do these characteristics guide the decision-making processes?
- Select a diagnosis and include an example of how research could assist in treatment.
- Include a minimum of three scholarly resources in addition to the course textbook.
Prepare this assignment according to the guidelines found in the APA Style Guide, located in the Student Success Center.
This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.
You are required to submit this assignment to Turnitin. Refer to the directions in the Student Success Center.
Order This Solution
49051 Millions developed by 10% and working benefit in 2009 was 15012 Millions that developed by 6%. Roche is contributed CHF. 9874 Millions on R&D in 2009. The free trade stream out 2009 was 8893 that was 79% more than 2008. The aggregate representative of Roche are 81507. Out of them 80115 are changeless. The Sales commitment is more from US that is 38% than West Europe that is 28%. Since pharmaceutical advertising exercises impact the endorsing conduct of specialists, it is of most extreme significance to basically dissect the cases made in the limited time material of the medications. The degree to which pharmaceutical organizations advance the benefits of their items and applicable clinical trails give to specialists are not examined in Pakistan. The consequences of the present logical examination demonstrate that untrustworthy and one-sided claims with respect to the pharmaceutical items are uncontrolled in Pakistan. These medication advancements impact the recommending conduct of the General Practitioners, Consultants in this manner representing one of the possibly significant reasons for outlandish solution. Roche Pakistan Ltd is a Member of IFPMA and PMA and take after their moral business rules to offer its items. Roche Paksitan Ltd is at sixth positioning in Pakistan Pharmaceutical Market and its yearly deal is Rs. 5.2 Billions out of 2009 in Pakistan.>GET ANSWER